Filing Flows › Bio Key International (BKYI) › License revenue
Bio Key International (BKYI) License revenue by quarter
Bio Key International's License revenue was $1.2M in Q2 2026 (second quarter 2026), -10% from Q1 2026. Over the last 7 quarters it ranged from $601K (Q4 2025) to $1.4M (Q1 2026).
| Quarter | License revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.2M | -10% | +53% |
| Q1 2026 | $1.4M | +127% | +24% |
| Q4 2025 | $601K | -35% | -41% |
| Q3 2025 | $918K | +14% | — |
| Q2 2025 | $806K | -27% | — |
| Q1 2025 | $1.1M | +7% | — |
| Q4 2024 | $1.0M | — | — |
Q2 2026 at a glance
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio Key International's License revenue?
Bio Key International's License revenue was $1.2M in Q2 2026 (second quarter 2026), -10% from Q1 2026.
How has Bio Key International's License revenue changed?
Over the last 7 quarters it ranged from $601K (Q4 2025) to $1.4M (Q1 2026).